Enediyne-lexitropsin DNA-targeted anticancer agents. Physicochemical and cytotoxic properties in human neoplastic cells in vitro, and intracellular distribution

Anti-Cancer Drug Design

Volumn 12, Issue 3, 1997, Pages 169-179

  Xie, Y ^a   Miller, G G ^a   Cubitt, S A ^a   Soderlind, K J ^a   Allalunis Turner, M J ^b   Lown, J W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Anticancer cytotoxins; DNA minor groove targeting; Enediyne; Lexitropsin

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DOXORUBICIN; DYNEMICIN A; LEXITROPSIN;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLORIMETRY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; FLUORESCENCE; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 0030946785     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ALLALUNIS-TURNER, M J, BARRON, G.M., DAY, R.S., III, DOBLER, K.D, & MIRZAYANS, R. (1993). Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiation Research, 134, 349-354.
2. ALLEY, M.C., SCUDIERO, D A, MONKS, A., HURSEY, M.L , CZERWINSKI, D.L., FINE, B.J., ABBOTT, J.G., MAYO, J.G., SHOEMAKER, R.H. & BOYD, M.R. (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research, 48, 589.
3. HIATT, A., MERLOCK, R , MAUCH, s. &. WRASIDLO. W (1994). Regulation of apoptosis in leukemic cells by analogs of Dynemicin A. Bioorganic and Medicinal Chemistry, 2, 315.
4. LOWN, J.W. (1988). Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer and potential cellular probes. Anti-Cancer Drug Design, 3, 25.
5. LOWN, J.W (1992). Lexitropsins in antiviral drug development. Antiviral Research, 17, 179.
6. LOWN, J.W., KROWICKI, K., BALZARINI, J., NEWMAN, R.A. & DE CLERCQ, E. (1989). Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation. Journal of Medical Chemistry, 32, 2368.
7. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55.
8. NICOLAOU, K C. & DAI, W.-M. (1991). Chemistry and biology of enediyne anticancer antibiotics. Angewandte Chemie, International Edition English, 30, 1387.
9. NICOLAOU, K.C., DAI, W.-M , TSAY, S.-C., ESTEVEZ, V A. & WRASIDLO, W. (1992a). Designed enediynes: a new class of DNA-cleaving molecules with potent and selective anticancer activity. Science, 256, 1172.
10. NICOLAOU, K.C., MALIGRES, P., SUZUKI, T., WENDEBORN, S.V., DAI, W.-M. & CHADHA, R.K. (1992b). Molecular design and chemical synthesis of potent enediynes. 1. Dynemicin model systems equipped with N-tethered triggering devices. Journal of the American Chemical Society, 114, 8890.
11. NICOLAOU, K. C., SCHREINER, E. P., IWABUCHI, Y. & SUZUKI, T. (1992c). Total synthesis of calicheamicin-dynemicin hybrid molecules. Angewandte Chemie, International Edition English, 31, 340.
12. NICOLAOU, K.C., SMITH, A.L &. YUE, E.W. (1993). Chemistry and biology of natural and designed enediynes. Proceedings of the National Academy of Science, USA, 90, 5881 and references therein.
13. TOKUDA, M., FUJIWARA, K., GOMIBUCHI, T. HIRAMA, M., UESUGI, M. & SUGIURA, Y. (1993). Synthesis of a hybrid molecule containing Neocarzinostatin chromophore analogue and minor groove binder. Tetrahedron Letters, 34, 669.
14. TOSHIMA, K., OHTA, K., OHASHI, A., NAKAMURA, T., NAKATA, M., TATSUTA, K. & MATSUMURA, S. (1995). Molecular design, chemical synthesis, and study of novel enediyne-sulfide systems related to the neocarzinostatin chromophore. Journal of the American Chemical Society, 117, 4822.
15. WITTMAN, M.D., KADOW, J.F., LANGLEY, D.R., VYAS, D.M., ROSE, W.C., SOLOMON, W. & ZEIN, N. (1995). The synthesis and biological activity of enediyne minor groove binding hybrids. Bioorganic and Medicinal Letters, 5, 1049.